Find Academic Supervisors

Courtney DumontView profile

Associate Professor

• Neural Stem Cell Biology
• Biomaterials
• Spinal Cord Injury Repair
• +3 more

Courtney Dumont is an Associate Professor in the Biomedical Engineering department at the College of Engineering , University of Miami. Her research focuses on neural stem cells and tissue-engineered microenvironments to repair nervous system injuries. Education: Not explicitly detailed in the text. Dr. Dumont’s recent publications highlight a multidisciplinary approach combining nanotechnology , biomaterials , and gene therapy to address neurological injuries. Her work spans spinal cord repair , anti-inflammatory strategies , and innovative treatments for SARS-CoV-2 . Key trends in her research include precision nanoparticle delivery systems , engineered scaffolds for cell transplantation , and modulating oxidative stress and inflammation to enhance regeneration. These studies emphasize the integration of biomaterial design with cell and gene therapies for clinical translation. Her lab, the NeuSTEM Research Group , develops multichannel bridges and hydrogel substrates to improve axon regeneration , myelination , and neuronal integration in rodent models.

• Neuroendocrinology
• Thyroid Hormone Signaling
• Brain Development
• +4 more

Federico Salas-Lucia is an Assistant Professor in the Department of Medicine, Division of Endocrinology at the University of Chicago's Pritzker School of Medicine. His research integrates neurobiology and endocrinology to investigate thyroid hormone mechanisms in brain development and function, utilizing human iPSC-derived models, transgenic mice, and multi-omics approaches. His educational background includes a BS in Biology from the University of Alicante (2012), an MSc in Neuroscience from University Miguel Hernandez (2014), and a PhD in Neuroscience from the same institution (2018). Dr. Salas-Lucia's research focuses on intracellular mechanisms customizing thyroid hormone action during human brain development. His laboratory examines how thyroid hormones regulate bioenergetic processes supporting neurogenesis, with emphasis on mitochondrial function in neural progenitor cells and epigenetic regulation via DNA methylation. Using cutting-edge iPSC-derived cerebral organoids and advanced imaging, his work bridges molecular mechanisms to clinical correlations between maternal thyroid levels and neurodevelopmental outcomes. Current investigations include thyroid hormone transport via MCT8, deiodinase activity (DIO2/DIO3), and nuclear receptor signaling in neural cells. His publication portfolio since 2018 shows accelerating productivity, with 23 publications through 2025 (8 in 2023 alone). The research demonstrates strong thematic continuity in thyroid-brain interactions , evolving from foundational rodent studies to sophisticated human iPSC models. Recent work increasingly incorporates multi-omics approaches and addresses clinical implications for disorders like Allan-Herndon-Dudley syndrome and Alzheimer's disease. Emerging Group Leader Award, International Society for Neurochemistry (2025) As principal investigator of the Salas-Lucia Laboratory, he directs research on thyroid hormone signaling in neural development. His work receives significant attention, with publications referenced in clinical guidelines and covered by multiple news outlets. The laboratory maintains active collaborations with leading endocrinology researchers including Antonio Bianco and Samuel Refetoff, and participates in interdisciplinary networks exploring metabolic regulation and neurodevelopment. Current projects investigate epigenetic mechanisms in thyroid-mediated cortical development and therapeutic strategies for thyroid hormone transport disorders.

Angela HagueView profile

Associate Professor

• Cell Biology
• Cancer Biology
• Educational Research
• +3 more

Dr. Angela Hague serves as Associate Professor in Health Sciences Education at Bristol Dental School, University of Bristol, where she bridges biomedical research and pedagogical innovation. A biomedical scientist with expertise in programme design, quality enhancement, and evidence-based educational leadership, she holds a B.Sc. from York and Ph.D. from Wales while fostering student wellbeing across undergraduate, postgraduate, and professional development contexts. Academic Background: B.Sc. in Biomedical Sciences, University of York Ph.D. in Molecular Biology, University of Wales Her dual research trajectory spans molecular oncology and health professions education. In cancer biology, she investigates apoptosis mechanisms, cell signaling pathways (PI3K/Akt, Wnt, NF-κB), and BAG-1 protein functions in oral and colorectal carcinomas, with recent work on BH3-mimetic drugs and tumor microenvironment interactions. Concurrently, her educational research examines feedback/feedforward dynamics in clinical workplaces, student engagement models, and curriculum design for evidence-based practice—evidenced by her 2022 publication on workplace learning environments. This synthesis of laboratory and educational scholarship enables translational approaches to both cancer therapeutics and healthcare training. Analysis of her 15 most recent publications (2010-2022) reveals evolving expertise: pre-2020 work dominated by molecular oncology (80% of output), shifting toward balanced contributions in educational research since 2020. Her cancer studies consistently target apoptosis dysregulation in epithelial cancers, while newer educational work addresses practical challenges in clinical pedagogy through qualitative analysis of student-staff interactions. Honors and Recognition: No formal awards or fellowships documented in source materials As an academic leader, Dr. Hague contributes to curriculum development and quality assurance frameworks at Bristol Dental School, though specific student supervision details remain unreported. Her research program likely involves collaborations with Bristol Medical School colleagues (noted in source affiliations) and may access university core facilities for molecular work, while her educational initiatives integrate directly into dental and medical training programs. Current grant activity isn't specified, but her dual-focus publications suggest sustained funding for both research domains.

• Medical Imaging
• Diffuse Optical Tomography
• Near-infrared Spectroscopy
• +5 more

Hamid Dehghani is a Professor of Medical Imaging at the University of Birmingham, affiliated with the Computer Science department, Healthcare Technologies Institute, and The Centre for Human Brain Health (CHBH). With an extensive research portfolio spanning electromagnetic wave propagation within biological tissue and image reconstruction from physiological measurements, he has established himself as a leading figure in biomedical optics. His primary research interests include: Diffuse Optical Tomography Near-infrared Spectroscopy Image Reconstruction Engineering Electromagnetic Wave Propagation in Biological Tissue Multi-Modality imaging techniques Near Infrared Imaging for breast cancer detection Diffuse Optical Imaging of the human brain Professor Dehghani has produced 358 research outputs throughout his career, with consistent publication activity since 1998. His recent work demonstrates a strong focus on functional near-infrared spectroscopy applications for studying brain hemodynamics in response to auditory stimuli, development of real-time imaging techniques, and standardization of terminology in the field. His research bridges engineering principles with clinical applications across neuroscience and oncology. Current research projects include: BioSMART: BIOreactor Spatial Mapping and Actuation in Real Time (EPSRC, 2023-2026) Live monitoring of foreign-body response in animals by diffuse Raman spectroscopy (NC3Rs, 2021-2025) Next generation deep tissue quantitative optical imaging (NIH, 2021-2025) Open, Extensible, Standardized, and Customizable Computational Tools for Optical Brain Mapping (NIH, 2024-2025) Mild Traumatic Brain Injury Biomarker Study (mTBI-Predict) (US Army, 2023-2028) His research fingerprint shows significant expertise in Diffuse Optical Tomography (100%), Near-infrared techniques (68%), Image Reconstruction (62%), and Near-infrared Spectroscopy (56%). Professor Dehghani is actively accepting PhD students and continues to make substantial contributions to medical imaging technology development.

Lorenzo FarinaView profile

Professor

• Network Medicine
• Bioinformatics
• Systems Biology
• +6 more

Lorenzo Farina is a Full Professor at Sapienza University of Rome's Faculty of Information Engineering, Computer Science and Statistics, specializing in Electronic and Computer Bioengineering (ING-INF/06). With over 25 years of academic leadership, he co-founded Italy's first Bioinformatics degree program and established key oncology precision medicine initiatives, maintaining active collaborations with Harvard Medical School's network medicine division. His educational background includes a cum laude Electronic Engineering degree and PhD in Systems Engineering, both from Sapienza University. These foundational studies evolved into pioneering work in positive linear systems theory, evidenced by his highly-cited Wiley textbook Positive Linear Systems: Theory and Applications (2000). Farina's research centers on network medicine – applying complex network science to molecular medicine since his 2004 breakthrough. His work spans cancer mechanisms (breast, glioblastoma, lung), drug repositioning (including COVID-19 applications), and liquid biopsy biomarker development. Current projects focus on miRNA-based network biomarkers for cancer diagnostics and immunotherapy response prediction, integrating multi-omics data through advanced computational frameworks. Analysis of his 15 most recent publications (2024-2025) reveals dominant themes: sexual dimorphism in cancer networks (MIRROR platform), immunotherapy response signatures, and critical examinations of AI's role in precision medicine. His work consistently bridges computational innovation with clinical applications, particularly in oncology diagnostics and therapeutic optimization. His scientific recognition includes: 2001 Guillemin-Cauer Award for best IEEE Transactions on Circuits and Systems article 2014 SysBio Award for annual best publication Farina actively mentors through interdisciplinary programs he established, including the Network Oncology doctoral program. His laboratory collaborations span Sapienza's Oncogenomics and Immunology Laboratories, Harvard's Channing Division of Network Medicine, and clinical departments in oncology and radiology, driving translational research from computational models to patient applications. He leads multiple research teams focused on network-based diagnostics, including the MIRROR platform for cancer disparity analysis and liquid biopsy development teams investigating circulating miRNA networks for early cancer detection across multiple malignancies.

Charles T. AndersonView profile

Professor

• Plant Cell Biology
• Cell Wall Structure and Function
• Cellulose Biochemistry
• +6 more

Charles T. Anderson is a Professor in the Department of Biology at Penn State University and a member of the Institute of Energy and the Environment (IEE). With an h-index of 37 and over 4,580 citations from 112 research outputs, his work has made significant contributions to plant cell biology and related fields. Dr. Anderson's educational background is not explicitly detailed in the provided information, but his extensive publication record spanning from 2003 to present demonstrates deep expertise in plant cell wall biology and related areas. Dr. Anderson's research focuses on plant cell wall structure and function, with particular emphasis on cellulose, pectin, and other polysaccharides in model systems like Arabidopsis thaliana. His work bridges molecular biology, biomechanics, and plant physiology to understand how cell walls contribute to plant growth, development, and environmental responses. Key research areas include stomatal dynamics, cell wall integrity responses, and the biomechanical properties of plant cells. His research has important implications for understanding plant responses to environmental stress and for applications in bioenergy and sustainable agriculture. Cell wall structure and function in plants Biomechanics of plant cell growth Stomatal guard cell physiology Cellulose and polysaccharide biosynthesis Plant responses to environmental stress Mechanisms of cell wall integrity maintenance Analysis of Dr. Anderson's recent publications reveals a strong focus on plant cell wall architecture, with particular attention to mechanical properties, structural components like cellulose and pectin, and the dynamics of stomatal guard cells. His work spans fundamental molecular mechanisms to broader applications in agriculture and climate resilience, with increasing emphasis on grass species and crop plants in recent years. Scientific Recognition With 112 research outputs and significant citation impact (h-index of 37), Dr. Anderson's work is widely recognized in the plant science community. His research has been featured in numerous high-impact journals and has attracted attention from news outlets, social media, and scholarly platforms. His work has been picked up by 38 news outlets, blogged about 8 times, referenced in Wikipedia pages, and discussed across various social media platforms including X (formerly Twitter) and Bluesky. Dr. Anderson serves as Principal Investigator on multiple active NSF-funded research projects, demonstrating leadership in plant cell biology research. He has also contributed to community resources through the acquisition of advanced microscopy equipment shared across the Penn State research community. Research Infrastructure Dr. Anderson plays a key role in maintaining and developing research infrastructure at Penn State, particularly in advanced microscopy capabilities. His successful acquisition of a Nikon SIM & STORM capable super-resolution fluorescent microscope has enhanced imaging capabilities for the broader research community.

• Nanomaterials
• Photophysics
• Sensor Development
• +6 more

Alice Sciortino is a Researcher at the Department of Physics and Chemistry - Emilio Segrè within the School of Science at the University of Palermo. Her position code PHYS-03/A indicates a research-focused academic track in the Italian university system. She maintains regular office hours on Tuesdays from 11:30 to 12:30 through the university's student portal system. Her research centers on advanced photonic nanomaterials with particular expertise in carbon nanodots , quantum dot superstructures , and metal-organic frameworks . Key research themes include: Nanoscale light emission and lasing phenomena Design of optical sensors for environmental and biomedical applications Photocatalytic systems for environmental remediation Hybrid nanomaterial interfaces for energy transfer Ultrafast photophysical characterization of nanomaterials Analysis of her recent publications (2023-2025) reveals a strong trajectory toward multifunctional nanoplatforms combining optical, magnetic, and catalytic properties. Her work increasingly bridges fundamental photophysics with practical applications in environmental monitoring and biomedicine, particularly in heavy metal detection (Hg²⁺, Ni²⁺) and tissue engineering. The publication record shows consistent high-output research with frequent collaborations across Italian institutions. While no formal scientific awards are documented in the provided materials, her extensive publication record in high-impact journals demonstrates significant scholarly contributions to nanophotonics and materials science. Dr. Sciortino's research program appears to focus on experimental nanomaterials development with strong emphasis on optical characterization techniques. Her work on carbon dot-MOF hybrids and quantum dot superparticles suggests leadership in designing next-generation photonic nanomaterials with tunable properties. The consistent funding evident from her publication output likely supports laboratory infrastructure for nanomaterials synthesis and advanced optical spectroscopy.

Paola ArlottaView profile

Professor

• Neuroscience
• Developmental Biology
• Stem Cell Biology
• +3 more

Paola Arlotta is the Golub Family Professor and Chair of the Department of Stem Cell and Regenerative Biology at Harvard University. She is a principal faculty member at the Harvard Stem Cell Institute, an Institute Member at the Broad Institute, and an Associate Member of the Stanley Center for Psychiatric Research. Her career spans groundbreaking work in cortical development and regenerative neuroscience. Education: M.S. in Biochemistry from the University of Trieste, Italy Ph.D. in Molecular Biology from the University of Portsmouth, UK Postdoctoral training in Neuroscience at Harvard Medical School Dr. Arlotta’s research focuses on defining molecular pathways that govern the differentiation of neural progenitors into cortical projection neurons, with a special interest in corticospinal neurons linked to ALS and spinal cord injury. Her lab bridges developmental neuroscience with stem cell engineering to study human-specific cortical development using 3D organoid models, aiming to uncover mechanisms of neurodevelopmental diseases. Scientific Contributions: 2024: Discovery of individual susceptibility to neurotoxicity in brain chimeroids 2024: Microglia’s role in fetal brain inflammation response 2022: Autism risk genes affect asynchronous neuron class development 2019: Reproducible generation of human cortical diversity in organoids Scientific Awards: Elected to the National Academy of Medicine for pioneering brain organoid research Her lab employs advanced techniques like single-cell RNA sequencing, FIN-seq for frozen tissue analysis, and in utero electroporation. She also explores neuronal reprogramming and myelin dynamics across axons, contributing to understanding cortical circuit assembly and repair.

• Biodynamics
• Biomechanics
• Exercise Physiology
• +5 more

Dr. Yasuo Kawakami is a Professor at the Faculty of Sport Sciences , Waseda University, with over two decades of academic leadership. His career spans roles as Vice President for Research Communication (2021–present), Director of the Human Performance Laboratory (2017–present), and multiple editorial/review positions for Japanese and international societies. Ph.D. and Ms. Sci. in Education from The University of Tokyo Research focus: biomechanics , muscle physiology , and human performance Degree of innovation: Developed humanoid robots with joint mechanisms mimicking human muscle-tendon dynamics Research Themes include: Muscle mechanics : In vivo behavior of skeletal muscle during movement, contraction types, and fatigue Biomechanics of locomotion : Running-induced changes in plantar fascia, foot arch deformation, and limb inertia Human-robot interaction : Joint mechanisms for energy-efficient dynamic movements Recent Publications highlight 3D muscle architecture , contraction-type-specific stiffness changes , and biomechanical adaptations in athletes versus untrained populations. His work demonstrates strong clinical relevance in muscle injury prevention and technical innovations in robotics. Awards include: JSB Best Podium Presentation (2023) Multiple Japan Biomechanics Society Encouragement Awards (2016–2023) Japan Training Science Society Academic Awards (2007, 2011) Early career 松井賞 from Japan Biomechanics Society (1992) As a thought leader , Kawakami has contributed to Science Council of Japan (2011–2023) and advised industry partners like Panasonic Corporation . His media impact spans 30+ TV/radio appearances (2017–2024) explaining muscle science to the public.

• Medical Imaging
• X-ray Physics
• Biomedical Physics
• +7 more

Michelle Croughan is a Research Fellow at the School of Physics and Astronomy, Monash University, where she conducts advanced research in x-ray imaging and biomedical physics. Her work integrates physics and physiology to study lung development and structural changes in disease models. Her research focuses on developing and applying novel x-ray imaging techniques such as directional dark-field and phase-contrast imaging to study microstructural changes in biological tissues. She applies these methods to preclinical models of cystic fibrosis and neonatal lung conditions, particularly in understanding lung aeration and vascular development in newborns with diaphragmatic hernia. Recent publications demonstrate a strong trend in combining computational image processing with synchrotron-based x-ray techniques to achieve high-resolution, quantitative insights into lung physiology and bone microstructure. Her work bridges physics, engineering, and medicine. Effect of prenatal diaphragmatic hernia on pulmonary arterial morphology (2025) Directional dark-field retrieval with single-grid x-ray imaging (2023) Fast implicit diffusive dark-field retrieval (2023) Sustained inflation improves lung aeration (2023) Accurate measures of regional lung air volumes (2022) Michelle Croughan leads research projects funded by the Australian Institute of Nuclear Science and Engineering (AINSE), including an active grant on directional dark-field imaging of small animal bones and teeth in cystic fibrosis models. She previously led an International Synchrotron Access Grant. There is no public information on student supervision or formal advising roles. She is part of a collaborative research network involving experts in medical physics and neonatal physiology, including Dr. Marcus Kitchen and other researchers at Monash University. Her work is conducted using advanced imaging facilities, likely including synchrotron sources, and focuses on translational preclinical applications.

Jessica GluckView profile

Assistant Professor

• Medical Textiles
• Nanotechnology
• Nonwovens
• +7 more

Jessica Gluck is an Assistant Professor in the Department of Textile Engineering, Chemistry and Science at the College of Textiles, North Carolina State University. Her interdisciplinary work bridges textile science with biomedical engineering and regenerative medicine. Education: Postdoctoral Fellowship, University of California, Davis Ph.D. in Molecular, Cellular & Integrative Physiology, University of California, Los Angeles (2013) M.S. in Biomedical Engineering, University of California, Los Angeles (2008) M.S. in Biomedical Textiles, North Carolina State University (2007) B.S. in Textile Technology, North Carolina State University (2005) Her research focuses on Medical Textiles, Nanotechnology, and Nonwovens , particularly in developing functional biomaterials for tissue engineering and wound healing. She designs advanced fibrous scaffolds, hydrogels, and composite structures that interact with biological systems at the cellular level, emphasizing immunomodulation, biocompatibility, and dynamic culture environments. Her recent publications (2022–2024) demonstrate a strong trend in biomimetic and bioactive textile-based systems , including vascular grafts, electrospun scaffolds with growth factors, conductive nanocomposites, and antiviral textiles. These works span materials science, bioengineering, and clinical translation, often targeting corneal, cardiovascular, and soft tissue regeneration. Research Groups: Faculty Research: Medical Textiles Faculty Research: Nanotechnology Faculty Research: Nonwovens Academics: Textile Engineering, Chemistry and Science Academics: Textile Technology Dr. Gluck actively mentors students and leads research projects in advanced medical textile development. She has secured research funding (implied by active lab output) and collaborates across disciplines to innovate in healthcare solutions using engineered textiles. Her lab explores next-generation materials for regenerative medicine, including smart scaffolds, controlled drug delivery systems, and standardized testing for antiviral efficacy.

• Cancer Biomechanics
• Tumor Microenvironment
• 3D Cell Culture
• +5 more

Dr. Anna Taubenberger is a Research Group Leader at the Mildred-Scheel Nachwuchszentrum Dresden, affiliated with BIOTEC at Technische Universität Dresden. She leads the Oncomechanics research group focused on understanding the biomechanical properties of cancer cells and their microenvironment. Dr. Taubenberger received her PhD in Engineering from TU Dresden (2004-2009), studied at the University of Talca, Chile (2001-2002), and completed her Bioprocess Engineering degree at TU Dresden (1999-2004). She was a Postdoctoral Fellow at BIOTEC Dresden (2013-2020) in the Group of Cellular Machines under Prof. Jochen Guck, and previously at Queensland University of Technology (2009-2012) in the Group of Regenerative Medicine under Prof. Dietmar Hutmacher. Her research focuses on how mechanical properties of cancer cells and their surrounding tissue affect metastatic potential. The Taubenberger group employs a combination of atomic force microscopy and real time deformability cytometry to characterize cell mechanical properties. They develop physiologically relevant 3D in vitro models to study how cell and microenvironment stiffness influence tumor spheroid growth, invasion, drug resistance, and metastasis. Key research aims include investigating the link between microenvironment mechanics and spheroid behavior, testing the functional role of cell mechanics in cancer progression, and identifying clinical markers for individualized breast cancer therapy. Analysis of Dr. Taubenberger's recent publications reveals a consistent focus on the biomechanical aspects of cancer progression. Her work bridges engineering approaches with biological questions, particularly examining how physical properties of the tumor microenvironment influence cancer cell behavior. The research spans from single-cell mechanics to tissue-level organization, with a special emphasis on breast cancer models and the connection between mechanical stress and cellular responses. DFG postdoctorial fellowship Early career fellowship, QUT Australia Dr. Taubenberger's research is funded by various European and German institutions through the Mildred-Scheel Nachwuchszentrum Dresden. She actively recruits Master's and PhD students for her research group, indicating her commitment to mentoring the next generation of scientists. Her work combines expertise in bioengineering, cancer biology, and biophysics to address fundamental questions about cancer mechanics. The Oncomechanics lab utilizes advanced techniques including atomic force microscopy and real time deformability cytometry to characterize mechanical properties across scales, from single cells to complex tissues. The group collaborates with various institutions to develop innovative models for studying cancer progression and potential therapeutic approaches.

• Endocrinology
• Metabolic Syndrome
• Pharmacology
• +7 more

Timo Mueller is a Director at the Institute for Diabetes and Obesity and a W3 Professor at the Walther-Straub Institute for Pharmacology and Toxicology , Ludwig-Maximilians-University Munich (LMU). His work bridges endocrinology , molecular pharmacology , and metabolic disorders to develop personalized preventive and therapeutic strategies for obesity and diabetes. Education: Animal Physiology, Philipps-University Marburg, Germany Ph.D. in Child and Adolescent Psychiatry, University of Duisburg-Essen, Germany (2009) His research on gut hormone-based therapies (e.g., GLP-1, GIP, glucagon) has revolutionized obesity and diabetes treatment. Key contributions include: Establishing GLP-1/GIP co-agonists for weight loss Refuting the role of alternatively activated macrophages in thermogenesis Decoding GIP receptor signaling in the central nervous system Engineering liver-targeted T3 delivery via glucagon His >190 publications span Cell , Nature , and Cell Metabolism . Awards include the Minkowski Award (2023), ERC Consolidator Grant (2022), and Werner-Creutzfeldt Prize (2023). Scientific Awards: Minkowski Award (EASD) - 2023 Werner-Creutzfeldt Prize (DDG) - 2023 Galenus-von-Pergamon Award - 2022 ERC Consolidator Grant (TRUSTED) - 2022 DZD Diabetes Award - 2015 As Head of the Division of Molecular Pharmacology at Helmholtz Munich since 2011 and Director since 2023 , Mueller leads an international team exploring central and peripheral metabolic signaling to combat obesity, diabetes, and comorbidities. Current projects focus on GIP receptor mechanisms and novel hormone-based therapies .

George Q. DaleyView profile

Professor

• Stem Cell Science
• Cancer Biology
• Hematology
• +5 more

George Q. Daley, MD, PhD, serves as Dean of Harvard Medical School and holds the Caroline Shields Walker Professorship of Medicine. He is a Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, with extensive affiliations including the Harvard Stem Cell Institute, Broad Institute of MIT and Harvard, and the Manton Center for Orphan Disease Research at Boston Children's Hospital. Daley's research focuses on using mouse and human disease models to identify mechanisms underlying blood disorders and cancer. His laboratory aims to define fundamental principles of stem cell contributions to tissue regeneration and repair, with applications for improving drug and transplantation therapies for patients with malignant and genetic bone marrow diseases. His work spans stem cell biology, cancer research, hematopoiesis, and regenerative medicine. Analysis of his recent publications reveals a consistent focus on stem cell applications in disease modeling, with particular emphasis on hematopoietic development, immunotherapy applications, and the translation of basic research into clinical applications. His work increasingly incorporates advanced technologies including single-cell analysis and genetic engineering approaches. NIH Director's Pioneer Award (2004) Judson Daland Prize from American Philosophical Society E. Mead Johnson Award from American Pediatric Society E. Donnall Thomas Prize from American Society of Hematology Janet Rowley Prize from International Chronic Myeloid Leukemia Foundation HMS A. Clifford Barger Excellence in Mentoring Award (2012) Daley has trained dozens of graduate students and postdoctoral fellows throughout his career. He has served in leadership roles for the International Society for Stem Cell Research, including as president (2007-08), and has been instrumental in developing international guidelines for stem cell research. His laboratory has made significant contributions to the field, including creating customized stem cells for treating genetic immune deficiencies and demonstrating the role of the LIN28/let-7 pathway in cancer. Daley leads research initiatives focused on stem cell applications for blood disorders and cancer treatment, with particular emphasis on translating basic discoveries into clinical applications through collaborations with the Dana-Farber Cancer Institute and Boston Children's Hospital.

• Organic Chemistry
• Green & Sustainable Chemistry
• Process Chemistry
• +4 more

Marti Roger is an Ordentlicher Professor (Full Professor) of Organic Chemistry and Process Chemistry at the University of Applied Sciences and Arts Western Switzerland (HES-SO), specifically at the Haute école d'ingénierie et d'architecture de Fribourg (HEIA-FR). He is a member of the ChemTech Institute of Chemical Technologies and holds a leadership role in research and education in sustainable chemistry. His academic career includes positions at ZHAW Winterthur/Wädenswil (2004–2009) and HEIA-FR since 2009. Education: B.Sc. in Chemistry from Technikum Winterthur and ETH Zurich, followed by a Ph.D. under Prof. Dr. D. Seebach at ETH Zurich. Postdoctoral research at Sandoz Pharma USA and industrial experience at Carbogen AG in pharmaceutical development and scale-up. Research focuses on synthetic organic chemistry, green chemistry, process development, and polymer science. Key projects include biodegradable facemasks (Public Mask project), smart hydrogels for tissue engineering, and sustainable biofuels from PHA. He leads or collaborates in HES-SO-funded projects addressing environmental challenges in materials and energy sectors. Teaching responsibilities include B.Sc. courses in organic chemistry (aromatic compounds, carboxylic acids, organometallic reactions) and M.Sc. courses in process chemistry and polymer applications. He emphasizes flow chemistry education and sustainable process design. Notable achievements include scaling up diformylxylose production from biomass, designing mini-CSTR reactors for oxidation reactions, and developing biodegradable polymers for medical use. His work balances academic innovation with industrial relevance, guided by life-cycle assessments for environmental impact minimization. Labs/Teams: Active in ChemTech Institute and collaborates with partners like Hepia, iTEC, and VS-Instituts. Projects span from bio-based materials to CO2-neutral fuels and eco-concretes.